Acute Beneficial Effects of a Rho-Kinase Inhibitor, Fasudil in Patients With Pulmonary Hypertension Due to Left Heart Disease

被引：0
|
作者：
Ishiyama, Masaki
Fujimoto, Naoki
Sato, Toru
Omori, Taku
Moriwaki, Keishi
Sugiura, Emiyo
Ogihara, Yoshito
Nakamori, Shiro
Kurita, Tairo
Dohi, Kaoru
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13710
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Evidence for Rho-kinase Activation in Patients with Pulmonary Arterial Hypertension
    Doe, Zhulanqiqige
    Fukumoto, Yoshihiro
    Takaki, Aya
    Hoshikawa, Yasushi
    Kondo, Takashi
    Shimokawa, Hiroaki
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 45 : S28 - S28
  • [32] Evidence for Rho-Kinase Activation in Patients With Pulmonary Arterial Hypertension
    Do E, Zhulanqiqige
    Fukumoto, Yoshihiro
    Takaki, Aya
    Tawara, Shunsuke
    Ohashi, Junko
    Nakano, Makoto
    Tada, Tomohiro
    Saji, Kenya
    Sugimura, Kohichiro
    Fujita, Hiroshi
    Hoshikawa, Yasushi
    Nawata, Jun
    Kondo, Takashi
    Shimokawa, Hiroaki
    CIRCULATION JOURNAL, 2009, 73 (09) : 1731 - 1739
  • [33] Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia
    Takase, Saeko
    Liao, Jingzhu
    Liu, Yue
    Tanaka, Rinako
    Miyagawa, Yasuhiro
    Sawahata, Masahito
    Sobue, Akira
    Mizoguchi, Hiroyuki
    Nagai, Taku
    Kaibuchi, Kozo
    Ozaki, Norio
    Yamada, Kiyofumi
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 931
  • [34] Neuroprotective Effects of Fasudil, a Rho-Kinase Inhibitor, After Spinal Cord Ischemia and Reperfusion in Rats
    Ohbuchi, Masahiko
    Kimura, Tetsu
    Nishikawa, Toshiaki
    Horiguchi, Takashi
    Fukuda, Masayuki
    Masaki, Yoko
    ANESTHESIA AND ANALGESIA, 2018, 126 (03): : 815 - 823
  • [35] Antianginal effect of fasudil, a Rho-kinase inhibitor, in patients with stable effort angina: A multicenter study
    Shimokawa, H
    Iinuma, H
    Kishida, H
    Nakashima, M
    Kato, K
    CIRCULATION, 2001, 104 (17) : 601 - 601
  • [36] Effects of combined therapy with a Rho-kinase inhibitor and prostacyclin on monocrotaline-induced pulmonary hypertension in rats
    Tawara, Shunsuke
    Fukumoto, Yoshihiro
    Shimokawa, Hiroaki
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (02) : 195 - 200
  • [37] Effect of Rho-kinase inhibitor on pulmonary vasoconstriction in monocrotaline-induced pulmonary hypertension rats
    Shimizu, M
    Minami, K
    Hirai, T
    Ishigaki, A
    Sasaki, Y
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 72P - 72P
  • [38] Protective effects of Rho kinase inhibitor fasudil on rats with chronic kidney disease
    Kushiyama, Taketoshi
    Oda, Takashi
    Yamamoto, Kojiro
    Higashi, Keishi
    Watanabe, Atsushi
    Takechi, Hanako
    Uchida, Takahiro
    Oshima, Naoki
    Sakurai, Yutaka
    Miura, Soichiro
    Kumagai, Hiroo
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2013, 304 (11) : F1325 - F1334
  • [39] Pleiotropic Effects of the Rho-kinase Inhibitor Fasudil After Subarachnoid Hemorrhage: A Review of Preclinical and Clinical Studies
    Satoh, Shin-ichi
    Ikegaki, Ichiro
    Kawasaki, Koh
    Asano, Toshio
    Shibuya, Masato
    CURRENT VASCULAR PHARMACOLOGY, 2014, 12 (05) : 758 - 765
  • [40] Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide
    McNamara, Patrick J.
    Murthy, Prashanth
    Kantores, Crystal
    Teixeira, Lilian
    Engelberts, Doreen
    van Vliet, Todd
    Kavanagh, Brian P.
    Jankov, Robert P.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2008, 294 (02) : L205 - L213
12345